← Open Payments lookup

MICHELLE TOMME: Open Payments

NPI 1467073379 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,072 in 72 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $941 · 2025 $1,072

Food & beverage: $1,072
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.8$160
Otsuka America Pharmaceutical, Inc.11$145
E.R. Squibb & Sons, L.L.C.8$144
ABBVIE INC.19$136
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$107
Janssen Pharmaceuticals, Inc5$96
Axsome Therapeutics, Inc.3$81
Collegium Pharmaceutical, Inc.3$43
Supernus Pharmaceuticals, Inc.2$41
Teva Pharmaceuticals USA, Inc.1$29

Products named: FANAPT, COBENFY, VRAYLAR, CAPLYTA, INVEGA SUSTENNA, REXULTI, Auvelity, ABILIFY ASIMTUFII.

Industry payments across ID — which companies pay providers there.